Clinical Trial Update: Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated [Phase 2]

View source ↗

Summary

Phase 2 safety and immunogenicity study of an inactivated Rift Valley Fever vaccine has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rift Valley Fever

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Rift Valley Fever | Phase 2 | Status: COMPLETED